QC
GMED icon

Quent Capital’s Globus Medical GMED Stock Holding History

Quent Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.32K Sell
80
-23
-22% -$1.96K ﹤0.01% 1330
2026
Q1 		$8.87K Sell
103
-22
-18% -$1.98K ﹤0.01% 1180
2025
Q4 		$10.9K Buy
125
+31
+33% +$2.35K ﹤0.01% 1135
2025
Q3 		$5.38K Buy
+94
New +$5.41K ﹤0.01% 1138
2025
Q2 		– Sell
-44
Closed -$3.22K – 676
2025
Q1 		$3.22K Hold
44
– – ﹤0.01% 1089
2024
Q4 		$3.64K Hold
44
– – ﹤0.01% 1092
2024
Q3 		$3.15K Hold
44
– – ﹤0.01% 1178
2024
Q2 		$3.01K Hold
44
– – ﹤0.01% 1167
2024
Q1 		$2.36K Hold
44
– – ﹤0.01% 1209
2023
Q4 		$2.35K Sell
44
-16
-27% -$780 ﹤0.01% 1189
2023
Q3 		$2.98K Hold
60
– – ﹤0.01% 1137
2023
Q2 		$3.57K Hold
60
– – ﹤0.01% 1108
2023
Q1 		$3.4K Hold
60
– – ﹤0.01% 1103
2022
Q4 		$4.46K Buy
60
+38
+173% +$2.59K ﹤0.01% 1030
2022
Q3 		$1K Hold
22
– – ﹤0.01% 1156
2022
Q2 		$1K Sell
22
-78
-78% -$5.13K ﹤0.01% 1102
2022
Q1 		$7K Buy
+100
New +$6.95K ﹤0.01% 977

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Quent Capital's GMED Position: Q2 2026 in Review

Quent Capital reduced its Globus Medical (GMED) stake by 22% in Q2 2026, selling an estimated $1.96K and leaving 80 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1330.

Quent Capital first reported a position in GMED in Q1 2022 and has held it in 17 quarters since. The position peaked at $10.9K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Quent Capital held 80 shares of Globus Medical worth $6.32K as of Q2 2026.
  • Quent Capital sold 23 Globus Medical shares in Q2 2026, an estimated $1.96K.
  • Globus Medical made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1330 holding.
  • Quent Capital first reported a position in Globus Medical in Q1 2022 and has held it in 17 quarters since.
  • Quent Capital's Globus Medical position peaked at $10.9K in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.